Journal
EMERGING INFECTIOUS DISEASES
Volume 15, Issue 3, Pages 436-440Publisher
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid1503.080923
Keywords
-
Categories
Funding
- Pediatric Dengue Vaccine Initiative
- United Nations International Children's Emergency Fund
- United Nations Development Programme
- World Bank
- World Health Organization
Ask authors/readers for more resources
Anti-dengue virus immunoglobulin M kits were evaluated. Test sensitivities were 21%-99% and specificities were 77%-98% compared with reference ELISAs. False-positive results were found for patients with malaria or past dengue infections. Three ELISAs showing strong agreement with reference ELISAs will be included in the World Health Organization Bulk Procurement Scheme.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
